Olly Olly Oxen-free! Utilising Risk-based Monitoring to More Effectively Identify and Mitigate Risk While Ensuring Patient Safety, Data Quality and Integrity
The PhUSE Deerfield Single Day Event was held at Advanced Clinical on July 21, 2016. The theme was risk-based monitoring (RBM). The day started with a keynote address and overview of RBM by Cheryle Evans of Advanced Clinical.
All of the presentations focused on how we can more effectively identify and mitigate risk while ensuring patient safety, data quality and integrity. The presentations were all of high quality and provided a variety of perspectives on RBM. The day ended with a lively panel discussion.
Advanced Clinical – Welcome & Keynote
Overview of Risk-based Monitoring and a Case Study of Implementation within a Mid-size CRO
- Cheryle Evans, Advanced Clinical
Operationalising Key Risk Indicators
- Katie Obermeyer, Advanced Clinical
Visual Analytical Tool - Patricia Wozniak, Advanced Clinical
Centralised Statistical Monitoring to Detect Data Integrity Issues - Alun Bedding, AstraZeneca
How Can I Contribute to Risk-based Monitoring? A Statistical Programmers Perspective
- Parag Shiralkar, Eliassen Group
PhUSE Update - Chris Hurley, MMS Holdings
Fraud Detection and Runway for RBM- Martin King & Naveen Katta, AbbVie
Update on Risk-based Site Selection Tool - Susan Thompson, FDA
The Role of Programmers in Defining and Execution of Trial Specific Reports as Part of Trial Set Up and Execution
- Sina Djali, Janssen R&D
Strategies for Managing Your Data to Support RBM Workflow - Casey Higgins, Chiltern
Runaway for RBM - Nareen Katta, AbbVie
Download the event brochure.
Patricia Wozniak, Advanced Clinical
Edwin Fung, Advanced Clinical
Photo from the Day: